Cite

HARVARD Citation

    Dey, A. et al. (2022). Musculoskeletal immune‐related adverse events with the use of checkpoint inhibitors in malignancy. Internal medicine journal. 52 (5), pp. 818-827. [Online]. 
  
Back to record